UW-Madison

Dr. Elizabeth Burnside and Dr. Jomol Mathew, who are both part of the All of Us Research leadership team at UW-Madison, recently received a National Institutes of Health (NIH) award for a project that will provide the first opportunity at UW to leverage real-time clinical data for research and contribute to the new National #COVID19 Cohort Collaborative, which aims to answer critical research questions to address the pandemic....

While the collection of health data and information has always been part of medicine, advancements in technology have made it easier to compile this information from various sources and parse it out to identify trends. While making sense out of large swaths of information is a difficult task, it’s exactly what Dr. Jomol Mathew was hired to do....

As UW Health and the University of Wisconsin begin scheduling participants for the AstraZeneca COVID-19 vaccine study, experts and leaders are focused on equity and inclusion to ensure a diverse population takes part in this phase 3 clinical trial. A diverse group of participants will give researchers the best understanding on how and if this vaccine works for everyone....

The following webinar, presented via a collaboration between the Foundation for Black Women's Wellness, the UW-Madison Collaborative Center for Health Equity, and the 'All of Us' Research Program at UW-Madison, highlights the importance of African American communities' participation in health research....

Our country needs a new path forward in the battle against COVID-19 Wisconsin's two medical schools are heading up this fight by launching innovative clinical trials, developing rapid diagnostic testing, studying the complexities of this virus and increasing our capacity to offer telehealth and virtual visits. Our health care professionals are working tirelessly. But these frontline fighters need support from everyone to limit the spread of this virus....

While the federal government has spent billions in an unprecedented effort to fast-track a vaccine that could be approved in just a few months, the rollout will be fraught with moral, ethical and political issues. Who gets it first? Who wants it? And who doesn’t? In this Q&A, UW-Madison's Dr. Jonathan Temte discusses these issues and more....